SynthesisPediatric surgery international2026
Advancing hirschsprung disease diagnosis: a systematic review of the development and application of artificial intelligence in histopathological analysis.
Synthesis in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Hirschsprung's disease (HD) is characterised by absence of ganglion cells in the distal large intestine, requiring accurate histopathological diagnosis. Conventional diagnostic methods are time-consuming, subjective, and demand specialised expertise. While artificial intelligence (AI) shows promise for improving diagnostic capacity, its clinical utility requires rigorous evaluation. Following PRISMA 2020 guidelines, this systematic review evaluated machine and deep learning techniques for HD diagnosis from histopathological images. A search of seven databases identified thirteen eligible studies (2016-2025). Studies were analysed for model architecture, computational workflows and diagnostic performances. Methodological quality and risk of bias were assessed using QUADAS-AI and PROBAST frameworks. HD image analysis has progressed from traditional processing to convolutional neural networks and transformer models. Deep learning outperformed conventional approaches with > 90% in ganglion cell detection and reducing diagnostic time by 50-95%. However, nine studies (69%) exhibited a high risk of bias due to small sample sizes, patch-level data partitioning, and lacking external test sets, raising concerns regarding overfitting and data leakage. AI methods demonstrated strong potential to support HD diagnosis by increasing accuracy, reducing variability and accelerating clinical decision-making. Future research should prioritise large multi-centre datasets, diverse staining techniques, external validation, and transparent reporting to facilitate reliable clinical integration.
Indexed as
Identifiers
42667407What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.